Changeflow GovPing Healthcare & Life Sciences Implantable Body Armor for Protecting Internal ...
Routine Notice Added Final

Implantable Body Armor for Protecting Internal Organs

Favicon for changeflow.com USPTO Patent Applications - Prosthetics (A61F)
Published
Detected
Email

Summary

The USPTO published patent application US20260108342A1 by inventor Michel GAGNER on April 23, 2026, covering an implantable body armor device for protecting internal organs. The device includes a flexible panel composed of layers of woven fibers configured to absorb impact energy, and is operable between a delivery configuration and a functional configuration. Filing date was April 11, 2025, under application number 19176694. This publication does not grant patent rights; it makes the application available for public inspection.

“An implantable body armor for placement at an implantation site within a ventral cavity of a human body is provided.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Prosthetics (A61F) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 206 changes logged to date.

What changed

The USPTO published patent application US20260108342A1 disclosing an implantable body armor device for placement within a ventral cavity of a human body. The device features a flexible panel with layers of woven fibers forming an impact-resistant structure designed to absorb impact energy, configurable between a compact delivery configuration and a larger functional configuration. The application is published under CPC classifications A61F 2/02, A61L 27/18, A61L 27/54, A61L 27/58, and related subclasses.

Manufacturers and medical device makers should note that this publication does not confer any enforceable rights or compliance obligations. It represents a patent application pending before the USPTO; the scope of any eventual patent claims may differ from the published disclosure. Parties developing competing implantable organ-protection devices should conduct freedom-to-operate analyses before commercializing similar technologies.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

IMPLANTABLE BODY ARMOR FOR PROTECTING INTERNAL ORGANS

Application US20260108342A1 Kind: A1 Apr 23, 2026

Inventors

Michel GAGNER

Abstract

An implantable body armor for placement at an implantation site within a ventral cavity of a human body is provided. The implantable body armor includes a flexible panel having an intercostal surface and a cavity surface opposite the intercostal surface, the flexible panel including layers of woven fibers forming an impact-resistant structure configured to absorb impact energy. The flexible panel can be further configurable between a delivery configuration and a functional configuration wherein, when in the delivery configuration, the flexible panel has an external surface area that is smaller than when in the functional configuration to facilitate a delivery of the implantable body armor to the implantation site.

CPC Classifications

A61F 2/02 A61L 27/18 A61L 27/54 A61L 27/58 A61F 2210/0004 A61F 2210/0076 A61F 2250/0067 A61F 2310/0097

Filing Date

2025-04-11

Application No.

19176694

View original document →

Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent application Medical device innovation
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!